{
    "organizations": [],
    "uuid": "8e0a47328a9d9e61b1b2b387cc1e68b639d6ab52",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-reata-announces-improvements-in-ki/brief-reata-announces-improvements-in-kidney-function-with-bardoxolone-methyl-maintained-for-two-years-in-pah-patients-from-lariat-trial-idUSFWN1Q21GW",
    "ord_in_thread": 0,
    "title": "BRIEF-Reata Announces Improvements In Kidney Function With Bardoxolone Methyl Maintained For Two Years In Pah Patients From Lariat Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Reata Pharmaceuticals Inc:\n* REATA ANNOUNCES IMPROVEMENTS IN KIDNEY FUNCTION WITH BARDOXOLONE METHYL MAINTAINED FOR TWO YEARS IN PAH PATIENTS FROM LARIAT TRIAL Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-13T05:42:00.000+02:00",
    "crawled": "2018-02-13T16:00:35.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "reata",
        "pharmaceutical",
        "inc",
        "reata",
        "announces",
        "improvement",
        "kidney",
        "function",
        "bardoxolone",
        "methyl",
        "maintained",
        "two",
        "year",
        "pah",
        "patient",
        "lariat",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}